Piramal Pharma

{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "179.85",
    "chg": -3.88,
    "chgp": "-2.11%",
    "dir": -1,
    "prev_price": "183.73",
    "mcapval": "24,312.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE0DK501011",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "66.99 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Gains 12.13%: 5 Key Factors Driving the Week’s Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-gains-1213-5-key-factors-driving-the-weeks-rally-3982997",
        "imagepath": "",
        "date": "2026-05-09 11:02:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>4 May:</strong> Flat quarterly financial trend reported amid mixed performance</p>\n                    <p><strong>5 May:</strong> Technical momentum shifts with mildly bearish signals</p>\n                    <p><strong>7 May:</strong> Intraday high surge of 8.42% and exceptional volume spike</p>\n                    <p><strong>7 May:</strong> Surge in value trading and institutional interest</p>\n                    <p><strong>7 May:</strong> Exceptional volume surge amid strong price rally</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.160.30</div></div>..."
      },
      {
        "title": "Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-exceptional-volume-surge-amid-strong-price-rally-3979822",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_most_active_equities_by_volume_3979822.png",
        "date": "2026-05-07 12:00:06",
        "description": "Piramal Pharma Ltd (PPLPHARMA) has emerged as one of the most actively traded stocks on 7 May 2026, registering a remarkable surge in volume and price amidst heightened volatility. The pharmaceutical and biotechnology small-cap stock outperformed its sector and broader market indices, signalling strong investor interest despite a recent downgrade in its mojo grade from Hold to Sell."
      },
      {
        "title": "Piramal Pharma Ltd Sees Surge in Value Trading Amid Volatility and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-sees-surge-in-value-trading-amid-volatility-and-institutional-interest-3979824",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_most_active_equities_by_value_3979824.png",
        "date": "2026-05-07 12:00:05",
        "description": "Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks by value on 7 May 2026, registering a remarkable 12.39% intraday gain and outperforming its sector by over 14%. The pharmaceutical small-cap has attracted significant institutional interest, with trading volumes soaring to nearly 3 crore shares and a total traded value exceeding ₹551 crore, signalling heightened investor participation amid volatile market conditions."
      },
      {
        "title": "Piramal Pharma Ltd Surges 8.42% to Day's High of Rs 175.7 — Outperforms Sector by 6.05 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-hits-intraday-high-with-842-surge-on-7-may-2026-3979764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_priceRelatedfactors_3979764.png",
        "date": "2026-05-07 11:16:01",
        "description": "The Sensex declined 0.18% on 7 May 2026, while Piramal Pharma Ltd surged 8.42%, outperforming its Pharmaceuticals &amp; Biotechnology sector by 6.05 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3975027",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_technicaldot_3975027.png",
        "date": "2026-05-05 08:08:02",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex interplay of momentum and trend signals that investors should carefully analyse."
      },
      {
        "title": "Piramal Pharma Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-reports-flat-quarterly-financial-trend-amid-mixed-performance-3973386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_fintrenddot_3973386.png",
        "date": "2026-05-04 08:00:14",
        "description": "Piramal Pharma Ltd’s latest quarterly results for March 2026 reveal a shift from previously positive financial trends to a flat performance, despite notable growth in net sales and profit before tax. The company’s financial health presents a complex picture, with strong operational metrics contrasting with subdued returns and elevated leverage, prompting a downgrade in its Mojo Grade to Sell."
      },
      {
        "title": "Piramal Pharma Declines 2.15% Despite Strong Quarterly Turnaround and Valuation Upgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-declines-215-despite-strong-quarterly-turnaround-and-valuation-upgrade-3971425",
        "imagepath": "",
        "date": "2026-05-02 11:01:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Apr:</strong> Technical momentum shifts amid mixed market signals</p>\n                    <p><strong>28 Apr:</strong> Technical momentum turns mildly bearish despite price gains</p>\n                    <p><strong>29 Apr:</strong> Strong quarterly turnaround reported with robust revenue and margin gains</p>\n                    <p><strong>29 Apr:</strong> Margin compression and losses raise concerns despite revenue stability</p>\n                    <p><strong>29 Apr:</strong> Technical momentum shifts again to sideways trend</p>\n                    <p><strong>30 Apr:</strong> Valuation shifts signal renewed price attractiveness</p>\n                </div>\n\n                <div cla..."
      },
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-3972744",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/PiramalPharmaLt_mojoScore_3972744.png",
        "date": "2026-05-02 10:10:02",
        "description": "Piramal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Piramal Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-valuation-shifts-signal-renewed-price-attractiveness-3969395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/PiramalPharmaLt_valuationdot_3969395.png",
        "date": "2026-04-30 08:00:57",
        "description": "Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent dip in share price and ongoing sector headwinds. This change reflects a significant reappraisal of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, signalling potential opportunities for investors amid a challenging pharmaceuticals and biotechnology landscape."
      }
    ],
    "total": 444,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Piramal Pharma Gains 12.13%: 5 Key Factors Driving the Week’s Rally

2026-05-09 11:02:14

Key Events This Week

4 May: Flat quarterly financial trend reported amid mixed performance

5 May: Technical momentum shifts with mildly bearish signals

7 May: Intraday high surge of 8.42% and exceptional volume spike

7 May: Surge in value trading and institutional interest

7 May: Exceptional volume surge amid strong price rally

Week Open

Rs.160.30

...

Read full news article

Piramal Pharma Ltd Sees Exceptional Volume Surge Amid Strong Price Rally

2026-05-07 12:00:06

Piramal Pharma Ltd (PPLPHARMA) has emerged as one of the most actively traded stocks on 7 May 2026, registering a remarkable surge in volume and price amidst heightened volatility. The pharmaceutical and biotechnology small-cap stock outperformed its sector and broader market indices, signalling strong investor interest despite a recent downgrade in its mojo grade from Hold to Sell.

Read full news article

Piramal Pharma Ltd Sees Surge in Value Trading Amid Volatility and Institutional Interest

2026-05-07 12:00:05

Piramal Pharma Ltd (PPLPHARMA) emerged as one of the most actively traded stocks by value on 7 May 2026, registering a remarkable 12.39% intraday gain and outperforming its sector by over 14%. The pharmaceutical small-cap has attracted significant institutional interest, with trading volumes soaring to nearly 3 crore shares and a total traded value exceeding ₹551 crore, signalling heightened investor participation amid volatile market conditions.

Read full news article

Piramal Pharma Ltd Surges 8.42% to Day's High of Rs 175.7 — Outperforms Sector by 6.05 Percentage Points

2026-05-07 11:16:01

The Sensex declined 0.18% on 7 May 2026, while Piramal Pharma Ltd surged 8.42%, outperforming its Pharmaceuticals & Biotechnology sector by 6.05 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-05 08:08:02

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite some bullish signals on weekly charts, monthly indicators suggest caution, reflecting a complex interplay of momentum and trend signals that investors should carefully analyse.

Read full news article

Piramal Pharma Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance

2026-05-04 08:00:14

Piramal Pharma Ltd’s latest quarterly results for March 2026 reveal a shift from previously positive financial trends to a flat performance, despite notable growth in net sales and profit before tax. The company’s financial health presents a complex picture, with strong operational metrics contrasting with subdued returns and elevated leverage, prompting a downgrade in its Mojo Grade to Sell.

Read full news article

Piramal Pharma Declines 2.15% Despite Strong Quarterly Turnaround and Valuation Upgrade

2026-05-02 11:01:37

Key Events This Week

27 Apr: Technical momentum shifts amid mixed market signals

28 Apr: Technical momentum turns mildly bearish despite price gains

29 Apr: Strong quarterly turnaround reported with robust revenue and margin gains

29 Apr: Margin compression and losses raise concerns despite revenue stability

29 Apr: Technical momentum shifts again to sideways trend

30 Apr: Valuation shifts signal renewed price attractiveness

Read full news article

Piramal Pharma Ltd is Rated Sell by MarketsMOJO

2026-05-02 10:10:02

Piramal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Piramal Pharma Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-04-30 08:00:57

Piramal Pharma Ltd has witnessed a notable shift in its valuation parameters, moving from a fair to an attractive rating, despite a recent dip in share price and ongoing sector headwinds. This change reflects a significant reappraisal of the company’s price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, signalling potential opportunities for investors amid a challenging pharmaceuticals and biotechnology landscape.

Read full news article

View All News